
    
      This is interventional single-center study, that will be done at Lahore General Hospital in
      which 95 beds are allocated for COVID-19 patients including ICUs and HDUs. Ethical approval
      will be obtained from research ethical committee of Lahore General hospital, Lahore. Informed
      consent will be obtained from all patients who will agree to publish their data in this
      research. Patient's privacy protection will be obeyed with the Helsinki Declaration.

      The aim of this study is to evaluate clinical effectiveness of this investigational drug,
      started a clinical trial of this drug on laboratory-confirmed COVID-19 patients at a tertiary
      care hospital of Lahore, Pakistan.
    
  